| 1 |
33325610 | Butein induces cellular senescence through reactive oxygen species-mediated p53 activation in osteosarcoma U-2 OS cells. | 2021 May |
1 |
| 2 |
33599867 | Prognostic value of p53 expression in hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer patients receiving neoadjuvant chemotherapy. | 2021 Jun |
1 |
| 3 |
31464976 | Lycorine Induces Apoptosis and G1 Phase Arrest Through ROS/p38 MAPK Signaling Pathway in Human Osteosarcoma Cells In Vitro and In Vivo. | 2020 Feb 1 |
1 |
| 4 |
32218822 | Changes in the gene mutation profiles of circulating tumor DNA detected using CAPP-Seq in neoadjuvant chemotherapy-treated advanced ovarian cancer. | 2020 Apr |
5 |
| 5 |
31372050 | Association of ki67 and tumor marker p53 in locally advanced breast cancer patients and evaluation of response to neoadjuvant chemotherapy: a survey in South Iran. | 2019 |
1 |
| 6 |
31428569 | Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer. | 2019 |
2 |
| 7 |
27637603 | The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma. | 2017 Feb |
1 |
| 8 |
28910957 | [Effects of cell cycle regulatory genes on breast cancer neo-adjuvant chemotherapy by M-FISH]. | 2017 Sep 12 |
2 |
| 9 |
25834606 | Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. | 2015 Mar |
3 |
| 10 |
24662134 | Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. | 2014 May |
1 |
| 11 |
23804139 | p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancer. | 2013 |
3 |
| 12 |
24335178 | Potential molecular mechanisms for improved prognosis and outcome with neoadjuvant chemotherapy prior to laparoscopical radical hysterectomy for patients with cervical cancer. | 2013 |
6 |
| 13 |
22977494 | Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer. | 2011 Mar |
1 |
| 14 |
18510179 | Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients. | 2008 Mar |
1 |